IL6 and sarcopenia: The mechanism involved is not fully understood but includes cytokine-driven hypermetabolism produced by TNF, IL-1β, and IL-6 (associated with resting energy expenditure and sarcopenia in RA patients), as well as the limitation of physical activity and insulin resistance [51,76].